Literature DB >> 23588196

Acetaminophen use and change in blood pressure in a hypertensive population.

Jesse Dawson1, Rachael Fulton, Gordon T McInnes, Ross Morton, David Morrison, Sandosh Padmanabhan, Jonathan Hewitt, Peter Meredith, Scott Muir, Anna F Dominiczak, Matthew R Walters.   

Abstract

OBJECTIVE: Recent data suggest that self-reported acetaminophen use is associated with increased risk of cardiovascular events and a rise in arterial blood pressure (BP). We investigated the association between acetaminophen use and BP in a large cohort of patients with hypertension using verified prescription data.
METHODS: We extracted data from the UK General Practice Research Database for all hypertensive patients aged 65 years or older who were prescribed acetaminophen and had BP measured both before and during acetaminophen treatment. Patients were grouped according to whether their antihypertensive treatment remained unchanged or not during the study period. The change in SBP and DBP during acetaminophen use was determined and compared with the change in BP in a group of nonacetaminophen-exposed people identified using propensity matching.
RESULTS: A total of 2754 acetaminophen-exposed individuals were included. BP rose slightly during the period of acetaminophen treatment wherein antihypertensive treatment was unchanged [change in SBP 1.6 [95% confidence interval (CI) 0.7-2.5) mmHg and change in DBP 0.5 (95% CI 0.1-1.0) mmHg)]. BP fell when new antihypertensive medications were prescribed. These BP changes were no different to those seen in matched nonacetaminophen-exposed individuals [between-group difference wherein antihypertensive treatment was unchanged was 0.6 (95% CI -0.6 to 1.9) mmHg and 0.5 (-0.1 to 1.1) mmHg for change in SBP and DBP, respectively].
CONCLUSION: We found no evidence of a sustained rise in blood pressure caused by acetaminophen treatment in a large population of patients with treated hypertension.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23588196     DOI: 10.1097/HJH.0b013e328360f6f8

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  6 in total

1.  Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial.

Authors:  Iain M MacIntyre; Emma J Turtle; Tariq E Farrah; Catriona Graham; James W Dear; David J Webb
Journal:  Circulation       Date:  2022-02-07       Impact factor: 39.918

Review 2.  Long-term adverse effects of paracetamol - a review.

Authors:  J C McCrae; E E Morrison; I M MacIntyre; J W Dear; D J Webb
Journal:  Br J Clin Pharmacol       Date:  2018-07-20       Impact factor: 4.335

Review 3.  Polypharmacy in Older Adults With Hypertension: A Comprehensive Review.

Authors:  Bertrand N Mukete; Keith C Ferdinand
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-07-27       Impact factor: 3.738

Review 4.  Cardiovascular risk associated with high sodium-containing drugs: A systematic review.

Authors:  Germain Perrin; Virginie Korb-Savoldelli; Alexandre Karras; Nicolas Danchin; Pierre Durieux; Brigitte Sabatier
Journal:  PLoS One       Date:  2017-07-06       Impact factor: 3.240

Review 5.  Current and Emerging Approaches for Pain Management in Hemophilic Arthropathy.

Authors:  Roberta Gualtierotti; Francesco Tafuri; Sara Arcudi; Pier Luigi Solimeno; Jacopo Acquati; Laura Landi; Flora Peyvandi
Journal:  Pain Ther       Date:  2022-01-12

6.  Evaluation of the relationship between effervescent paracetamol and blood pressure: clinical trial.

Authors:  Mencia Benitez-Camps; Ernest Vinyoles-Bargalló; Oriol Rebagliato-Nadal; Rosa Morros-Pedrós; Helena Pera-Pujadas; Antoni Dalfó-Baqué; Ignacio López-Pavón; Carlos Roca-Sánchez; Rosa Maria Coma-Carbó; Mariano De La Figuera Von Wichmann; Lucas Mengual-Martínez; Carmen Yuste-Marco; Montserrat Teixidó-Colet; Josep M Pepió i Vilaubí; Riera Ciurana-Tost; Rosa Pou-Vila; Ma Antònia Vila-Coll; Josep Maria Bordas-Julve; Rosa Aragonès-Forès; Francisco Javier Pelegrina-Rodríguez; Josep Agudo-Ugena; Carlos Blanco-Mata; Jon de la Iglesia Berrojalbiz; Natalia Burgos-Alonso; Maria Cruz Gómez-Fernández
Journal:  BMC Cardiovasc Disord       Date:  2015-12-10       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.